Proteomic Profiling of Mucosal and Submucosal Colonic Tissues Yields Protein Signatures that Differentiate the Inflammatory Colitides

被引:51
作者
M'Koma, Amosy E. [1 ,2 ,3 ]
Seeley, Erin H. [4 ]
Washington, Mary K. [3 ,5 ]
Schwartz, David A. [3 ,6 ]
Muldoon, Roberta L. [2 ,3 ]
Herline, Alan J. [2 ,3 ]
Wise, Paul E. [2 ,3 ]
Caprioli, Richard M. [4 ]
机构
[1] Meharry Med Coll, Sch Med, Dept Biochem & Canc Biol, Nashville, TN 37208 USA
[2] Vanderbilt Univ, Med Ctr, Dept Gen Surg, Nashville, TN USA
[3] Vanderbilt Univ, Ctr Inflammatory Bowel Dis, Med Ctr, Nashville, TN USA
[4] Vanderbilt Univ, Med Ctr, Mass Spectrometry Res Ctr, Nashville, TN USA
[5] Vanderbilt Univ, Dept Surg Pathol, Med Ctr, Nashville, TN USA
[6] Vanderbilt Univ, Dept Gastroenterol, Med Ctr, Nashville, TN USA
关键词
ulcerative colitis; Crohn's colitis; colon tissue profiling; proteomics; CROHNS-DISEASE; ULCERATIVE-COLITIS; BOWEL-DISEASE; EXPRESSION; POUCH; CALPROTECTIN; DIAGNOSIS; HISTOLOGY; MARKERS; DEPTH;
D O I
10.1002/ibd.21442
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Differentiating ulcerative colitis (UC) from Crohn's colitis (CC) can be difficult and may lead to inaccurate diagnoses in up to 30% of inflammatory bowel disease (IBD) patients. Much of the diagnostic uncertainty arises from the overlap of clinical and histologic features. Matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) permits a histology-directed cellular protein analysis of tissues. As a pilot study, we evaluated the ability of histology-directed MALDI-MS to determine the proteomic patterns for potential differences between CC and UC specimens. Methods: Mucosal and submucosal layers of CC and UC colon resection samples were analyzed after histologic assessment. To determine whether MALDI-MS would distinguish inflammation, the uninflamed (n = 21) versus inflamed submucosa (n = 22) were compared in UC and the uninflamed (n = 17) versus inflamed submucosa (n = 20) in CC. To determine whether there were proteomic differences between the colitides, the uninflamed UC submucosa (n = 21) was compared versus the uninflamed CC submucosa (n = 17), the inflamed UC submucosa (n = 22) was compared versus the inflamed CC submucosa (n = 20), and inflamed UC mucosa versus inflamed CC mucosa. Pairwise statistics comparisons of the subsets were performed. Results: Pairwise comparative analyses of the clinical groups allowed identifying subsets of features important for classification. Comparison of inflamed versus uninflamed CC submucosa showed two significant peaks: m/z 6445 (P = 0.0003) and 12692 (P = 0.003). In the case of inflamed versus uninflamed UC submucosa, several significant differentiating peaks were found, but classification was worse. Comparisons of the proteomic spectra of inflamed submucosa between UC and CC identified two discrete significant peaks: m/z 8773 (P = 0.006) and 9245 (P = 0.0009). Comparisons of the proteomic spectra of uninflamed submucosa between UC and CC identified three discrete significant peaks: m/z 2778 (P = 0.005), 9232 (P = 0.005), and 9519 (P = 0.005). No significantly different features were found between UC and CC inflamed mucosa. Conclusions: MALDI-MS was able to distinguish CC and UC specimens while profiling the colonic submucosa. Further analyses and protein identification of the differential protein peaks may aid in accurately diagnosing IBD and developing appropriate personalized therapies.
引用
收藏
页码:875 / 883
页数:9
相关论文
共 41 条
[1]   Comparison of RANTES expression in Crohn's disease and ulcerative colitis: an aid in the differential diagnosis? [J].
Ansari, N. ;
Abdulla, J. ;
Zayyani, N. ;
Brahmi, U. ;
Taha, S. ;
Satir, A. A. .
JOURNAL OF CLINICAL PATHOLOGY, 2006, 59 (10) :1066-1072
[2]   Identification of Markers of Taxane Sensitivity Using Proteomic and Genomic Analyses of Breast Tumors from Patients Receiving Neoadjuvant Paclitaxel and Radiation [J].
Bauer, Joshua A. ;
Chakravarthy, A. Bapsi ;
Rosenbluth, Jennifer M. ;
Mi, Deming ;
Seeley, Erin H. ;
Granja-Ingram, Nara De Matos ;
Olivares, Maria G. ;
Kelley, Mark C. ;
Mayer, Ingrid A. ;
Meszoely, Ingrid M. ;
Means-Powell, Julie A. ;
Johnson, Kimberly N. ;
Tsai, Chiaojung Jillian ;
Ayers, Gregory D. ;
Sanders, Melinda E. ;
Schneider, Robert J. ;
Formenti, Silvia C. ;
Caprioli, Richard M. ;
Pietenpol, Jennifer A. .
CLINICAL CANCER RESEARCH, 2010, 16 (02) :681-690
[3]   How could pathologists improve the initial diagnosis of colitis? Evidence from an international workshop [J].
Bentley, E ;
Jenkins, D ;
Campbell, F ;
Warren, B .
JOURNAL OF CLINICAL PATHOLOGY, 2002, 55 (12) :955-960
[4]   Serologic markers in inflammatory bowel disease [J].
Bossuyt, X .
CLINICAL CHEMISTRY, 2006, 52 (02) :171-181
[5]  
BUCKELL NA, 1980, GASTROENTEROLOGY, V79, P19
[6]   Molecular classification of Crohn's disease and ulcerative colitis patients using transcriptional profiles in peripheral blood mononuclear cells [J].
Burczynski, ME ;
Peterson, RL ;
Twine, NC ;
Zuberek, KA ;
Brodeur, BJ ;
Casciotti, L ;
Maganti, V ;
Reddy, PS ;
Strahs, A ;
Immermann, F ;
Spinelli, W ;
Schwertschlag, U ;
Slager, AM ;
Cotreau, MM ;
Dorner, AJ .
JOURNAL OF MOLECULAR DIAGNOSTICS, 2006, 8 (01) :51-61
[7]   Profiling and imaging proteins in tissue sections by MS [J].
Chaurand, P ;
Schwartz, SA ;
Caprioli, RM .
ANALYTICAL CHEMISTRY, 2004, 76 (05) :86A-93A
[8]   Integrating histology and imaging mass spectrometry [J].
Chaurand, P ;
Schwartz, SA ;
Billheimer, D ;
Xu, BGJ ;
Crecelius, A ;
Caprioli, RM .
ANALYTICAL CHEMISTRY, 2004, 76 (04) :1145-1155
[9]   ANALYSIS OF RELIABILITY OF DETECTION AND DIAGNOSTIC VALUE OF VARIOUS PATHOLOGICAL FEATURES IN CROHNS-DISEASE AND ULCERATIVE-COLITIS [J].
COOK, MG ;
DIXON, MF .
GUT, 1973, 14 (04) :255-262
[10]   A novel histology-directed strategy for MALDI-MS tissue profiling that improves throughput and cellular specificity in human breast cancer [J].
Cornett, Dale S. ;
Mobley, James A. ;
Dias, Eduardo C. ;
Andersson, Malin ;
Arteaga, Carlos L. ;
Sanders, Melinda E. ;
Caprioli, Richard M. .
MOLECULAR & CELLULAR PROTEOMICS, 2006, 5 (10) :1975-1983